Premier Integrated Labs is leading efforts to advance early diagnosis and understanding of Alzheimer’s disease in Malaysia – a critical step in improving outcomes for patients and families affected by the condition.
On 22 April 2025, Premier Integrated Labs (PIL) launched a nationwide Continuing Medical Education tour in Penang, in collaboration with Mayo Clinic Laboratories and Eisai Co., Ltd.
The inaugural event brought together neurology specialists from both public and private hospitals to spotlight the importance of early detection and biomarker-based testing for Alzheimer’s.
Dr Jaron L from Mayo Clinic Laboratories highlighted the benefits of biomarker-driven diagnostics, while Dr Yew Keong Ng from Eisai shared insights into the evolving diagnostics landscape in Malaysia. The strong turnout underscored the clinical community’s shared commitment to tackling one of the most pressing neurological challenges of our time.
Separately, PIL also participated in a strategic session with YBhg Datuk Dr Muhammad Radzi Abu Hassan, former Director-General of Health, Malaysia Ministry of Health, to present updates on the ongoing study “Whole Exome Sequencing in Late-Onset Alzheimer’s Disease (LOAD) in Peninsular Malaysia.” The study seeks to uncover genomic markers and better understand the clinical characteristics of LOAD among local patients.
Representing PIL were CEO Hareeff Muhammed, Sayyidi Hamzi, and Dr Zubaidah, alongside collaborators Dr Hans Prakash (Institute for Medical Research) and Dr Cheah Wee Kooi (Hospital Taiping).
These initiatives reflect PIL’s dedication to fostering clinical collaboration, advancing diagnostics, and driving evidence-based care in the fight against Alzheimer’s disease.
Related Stories
-marks-nation-s-historic-first-in-early-stage-oesophageal-cancer-treatment.png?sfvrsn=4932c57_1)
Pantai Hospital Kuala Lumpur Marks Nation’s Historic First in Early-stage Oesophageal Cancer Treatment
Pantai Hospital Kuala Lumpur (PHKL) has achieved a historic milestone in gastrointestinal care, successfully performing Malaysia's first 360-degree circumferential Endoscopic Submucosal Dissection (ESD) for early-stage oesophageal cancer.
Parkway Rehab Champions Care Without Barriers
At IHH Healthcare Singapore, care doesn’t stop at the clinic doors. We believe healthcare should be accessible, especially for those who face barriers in receiving it.
Parkway Radiology Reopens Upgraded Nuclear Medicine and PET Centre at Mount Elizabeth Hospital
Parkway Radiology’s Nuclear Medicine and PET Centre at Mount Elizabeth Hospital has officially reopened following a comprehensive renovation, offering an enhanced patient experience within a modern and welcoming environment.
Fortis Achieves Stronger ESG Rating and Rises to #2 Among Healthcare Peers
Fortis Healthcare has received its latest ESG rating from the National Stock Exchange, and we are pleased to share significant progress in both our score and sector ranking.
Gleneagles Hospital Hong Kong Advances Regional Collaboration in Venous Disease Care
Gleneagles Hospital Hong Kong, part of the IHH Healthcare network, has entered into a strategic partnership with the Asian Venous Academy and Dr Smile Medical Group to advance collaboration in venous disease related services, research and education.
IHH Singapore and Medistra Hospital Sign MoU to Strengthen Liver Disease Care in the Region
IHH Healthcare Singapore and Medistra Hospital signed a Memorandum of Understanding (MoU) on 22 January 2026, marking a significant step forward in advancing liver disease services and strengthening healthcare quality across the region.
